KaloBios (KBIOQ) Completes Chapter 11 Bankruptcy; Acquires Benznidaz...

KaloBios (KBIOQ) Completes Chapter 11 Bankruptcy; Acquires Benznidazole Development Rights
StreetInsider.com
KaloBios Pharmaceuticals, Inc. (OTC: KBIOQ) announced that it has emerged from Chapter 11 bankruptcy and has also acquired the rights from Savant Neglected Diseases LLC to develop benznidazole for the treatment of Chagas disease. “The Company ...
KaloBios Emerges from Chapter 11 BankruptcyGenetic Engineering & Biotechnology News
KaloBios Emerges from Bankruptcy, Buys Tropical Disease DrugWall Street Journal
KaloBios emerges from bankruptcy, raises $14M in recapFierceBiotech

all 8 news articles »